No known cause: leukemia research.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001772:Blood Cell Count; D002986:Clinical Trials as Topic; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D017404:In Situ Hybridization, Fluorescence; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D018579:Patient Selection; D010677:Philadelphia Chromosome; D016133:Polymerase Chain Reaction; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use; D015996:Survival Rate; D013997:Time Factors; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D016898:Interferon-alpha; D011743:Pyrimidines; D006918:Hydroxyurea